April 23, 2018 / 4:43 PM / 8 months ago

BRIEF-Elusys Therapeutics Awarded $25.2 Mln Delivery Order By U.S. Govt. For Anthim (Obiltoxaximab)

April 23 (Reuters) - Elusys Therapeutics Inc:

* ELUSYS THERAPEUTICS INC SAYS HAS BEEN AWARDED A $25.2 MILLION FOLLOW-ON DELIVERY ORDER BY U.S. GOVERNMENT FOR ANTHIM (OBILTOXAXIMAB)

* ELUSYS THERAPEUTICS - ANTHIM DELIVERY ORDER IS BY BIOMEDICAL ADVANCED RESEARCH & DEVELOPMENT AUTHORITY, PART OF U.S. DEPARTMENT. OF HEALTH & HUMAN SERVICES

* ELUSYS THERAPEUTICS INC SAYS ANTHIM IS INDICATED IN ADULT AND PEDIATRIC PATIENTS FOR TREATMENT OF INHALATIONAL ANTHRAX

* ELUSYS THERAPEUTICS - THE $25.2 MILLION FOLLOW-ON DELIVERY ORDER FOR ANTHIM WILL INCREASE INVENTORY OF ANTHIM STORED IN THE STRATEGIC NATIONAL STOCKPILE Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below